Assessment of Three Basic Progressive Lens Designs
Completed · Not applicable
Conditions studied: Presbyopia
In brief
This clinical trial investigates the differences between three different progressive addition lens designs. It is a non-invasive double-masked randomized clinical investigation. For this study, 80 participants will be recruited.
Key facts
- Study ID
- NCT05252871
- Run by
- Western University of Health Sciences
- People needed
- 80
- Starts
- 2021-12-09
- Expected to finish
- 2022-06-06
- Last updated by the study team
- 2024-08-15
Who can join
Age: 45 and older, up to 70. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age: 45 to 70 years old.
- Visual Acuity: far \& near monocular: cc ≥ 20/20 (decimal cc ≥ 1.0)
- Normal binocular vision (at distance \& near: no strabismus on cover testing, aligning prism of less than 2Δ horizontally or vertically, stereoacuity of 2' or better at distance and near).
- Prescription is in the range:
- Spherical power: less than +/-6.00 D
- Cylindrical power: less than -2.75 D
- Addition: 1.50 D - 2.50 D
- Difference in power (spherical equivalent) between eyes: less than 2.00 D
You may not qualify if…
- Have never worn any progressive lens design.
- First prescription for progressive lenses.
- Prescription found during visit#1 varies from current prescription more than 0.50 D in any meridian.
- Currently wearing single vision lenses with accommodative support.
- Double vision or prismatic prescription in current glasses.
- Known ocular disease including strabismus, any pathology, any eye surgeries that may affect visual acuity.
- Use of systemic or ocular medications that are likely to affect vision.
- Balance problem/vertigo problem.
- Concurrent participation in other vision-related research.
Where it is running
- Western University of Health Sciences — Pomona, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.